NL-OMON51815招募中4 期
What is the optimal antithrombotic strategy in patients with atrial fibrillation having acute coronary syndrome or undergoing percutaneous coronary intervention? - WOEST 3
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. >=18 years of age
- •2. Undergoing PCI or presenting with ACS with elevated cardiac markers
- •(CK/CK-MB, troponin)
- •3. History of or newly diagnosed atrial fibrillation or flutter with a
- •long-term (>= 1 year) indication for OAC
排除标准
- •1. Contra indication to edoxaban
- •2. < 3 months after any stroke
- •3. < 3 months after venous thrombo embolism
- •4. Mechanical heart valve prosthesis
- •5. Moderate to severe mitral valve stenosis
- •6. Intracardiac thrombus
研究者
相似试验
撤回
4 期
What is the optimal antithrombotic strategy in patients presenting with acute coronary syndrome having atrial fibrillation with indication for anticoagulants?myocardial infarctionNL-OMON49131Sint Antonius Ziekenhuis2,500
进行中（未招募）
1 期
What is the optimal blood thinner strategy in patients with atrial fibrillation presenting with a heart attack?Acute coronary syndrome in patients with known or new atrial fibrillation with indication for oral anticoagulantsEUCTR2019-004805-28-NLSt. Antonius Hospital2,500
招募中
1 期
WOEST-3Atrial fibrillationAcute coronary syndromeChronic coronary syndromeCTIS2022-502140-13-00St Antonius Hospital2,550
进行中（未招募）
1 期
What is the optimal strategy of blood thinners in patients with atrial fibrillation and a heart attack or coronary stent?EUCTR2022-001298-30-NLSt. Antonius Hospital2,000
尚未招募
Unknown
Optimal antithrombotic strategy for treatment of atherosclerotic cardiovascular disease – comparison of clopidogrel-based antiplatelet agent treatment versus aspirin plus low dose rivaroxaban therapy (OACART study)KCT0008458Seoul National University Bundang Hospital2,758